Cargando…

Increased Plasma Levels of Triglyceride-Enriched Lipoproteins Associate with Systemic Inflammation, Lipopolysaccharides, and Gut Dysbiosis in Common Variable Immunodeficiency

PURPOSE: Triglycerides (TG) and their major transport lipoprotein in the circulation (VLDL) appear to be related to inflammation. Patients with common variable immunodeficiency (CVID) have inflammatory complications associated with gut microbial dysbiosis. We hypothesized that CVID patients have dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Macpherson, Magnhild E., Skarpengland, Tonje, Hov, Johannes R., Ranheim, Trine, Vestad, Beate, Dahl, Tuva B., Fraz, Mai S. A., Michelsen, Annika E., Holven, Kirsten B., Fevang, Børre, Berge, Rolf K., Aukrust, Pål, Halvorsen, Bente, Jørgensen, Silje F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353950/
https://www.ncbi.nlm.nih.gov/pubmed/36995502
http://dx.doi.org/10.1007/s10875-023-01475-x
_version_ 1785074814223908864
author Macpherson, Magnhild E.
Skarpengland, Tonje
Hov, Johannes R.
Ranheim, Trine
Vestad, Beate
Dahl, Tuva B.
Fraz, Mai S. A.
Michelsen, Annika E.
Holven, Kirsten B.
Fevang, Børre
Berge, Rolf K.
Aukrust, Pål
Halvorsen, Bente
Jørgensen, Silje F.
author_facet Macpherson, Magnhild E.
Skarpengland, Tonje
Hov, Johannes R.
Ranheim, Trine
Vestad, Beate
Dahl, Tuva B.
Fraz, Mai S. A.
Michelsen, Annika E.
Holven, Kirsten B.
Fevang, Børre
Berge, Rolf K.
Aukrust, Pål
Halvorsen, Bente
Jørgensen, Silje F.
author_sort Macpherson, Magnhild E.
collection PubMed
description PURPOSE: Triglycerides (TG) and their major transport lipoprotein in the circulation (VLDL) appear to be related to inflammation. Patients with common variable immunodeficiency (CVID) have inflammatory complications associated with gut microbial dysbiosis. We hypothesized that CVID patients have disturbed TG/VLDL profiles associated with these clinical characteristics. METHODS: We measured plasma concentrations of TGs, inflammatory markers, and lipopolysaccharide (LPS) in 95 CVID patients and 28 healthy controls. Additionally, in 40 CVID patients, we explored plasma lipoprotein profiling, fatty acid, gut microbial dysbiosis, and diet. RESULTS: TG levels were increased in CVID patients as compared to healthy controls (1.36 ± 0.53 mmol/l versus 1.08 ± 0.56 [mean, SD], respectively, P = 0.008), particularly in the clinical subgroup “Complications,” characterized by autoimmunity and organ-specific inflammation, compared to “Infection only” (1.41 mmol/l, 0.71[median, IQR] versus [1.02 mmol/l, 0.50], P = 0.021). Lipoprotein profile analyses showed increased levels of all sizes of VLDL particles in CVID patients compared to controls. TG levels correlated positively with CRP (rho = 0.256, P = 0.015), IL-6 (rho = 0.237, P = 0.021), IL-12 (rho = 0.265, P = 0.009), LPS (r = 0.654, P = 6.59 × 10(−13)), CVID-specific gut dysbiosis index (r = 0.315, P = 0.048), and inversely with a favorable fatty acid profile (docosahexaenoic acid [rho =  − 0.369, P = 0.021] and linoleic acid [rho =  − 0.375, P = 0.019]). TGs and VLDL lipids did not appear to be associated with diet and there were no differences in body mass index (BMI) between CVID patients and controls. CONCLUSION: We found increased plasma levels of TGs and all sizes of VLDL particles, which were associated with systemic inflammation, LPS, and gut dysbiosis in CVID, but not diet or BMI. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10875-023-01475-x.
format Online
Article
Text
id pubmed-10353950
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-103539502023-07-20 Increased Plasma Levels of Triglyceride-Enriched Lipoproteins Associate with Systemic Inflammation, Lipopolysaccharides, and Gut Dysbiosis in Common Variable Immunodeficiency Macpherson, Magnhild E. Skarpengland, Tonje Hov, Johannes R. Ranheim, Trine Vestad, Beate Dahl, Tuva B. Fraz, Mai S. A. Michelsen, Annika E. Holven, Kirsten B. Fevang, Børre Berge, Rolf K. Aukrust, Pål Halvorsen, Bente Jørgensen, Silje F. J Clin Immunol Original Article PURPOSE: Triglycerides (TG) and their major transport lipoprotein in the circulation (VLDL) appear to be related to inflammation. Patients with common variable immunodeficiency (CVID) have inflammatory complications associated with gut microbial dysbiosis. We hypothesized that CVID patients have disturbed TG/VLDL profiles associated with these clinical characteristics. METHODS: We measured plasma concentrations of TGs, inflammatory markers, and lipopolysaccharide (LPS) in 95 CVID patients and 28 healthy controls. Additionally, in 40 CVID patients, we explored plasma lipoprotein profiling, fatty acid, gut microbial dysbiosis, and diet. RESULTS: TG levels were increased in CVID patients as compared to healthy controls (1.36 ± 0.53 mmol/l versus 1.08 ± 0.56 [mean, SD], respectively, P = 0.008), particularly in the clinical subgroup “Complications,” characterized by autoimmunity and organ-specific inflammation, compared to “Infection only” (1.41 mmol/l, 0.71[median, IQR] versus [1.02 mmol/l, 0.50], P = 0.021). Lipoprotein profile analyses showed increased levels of all sizes of VLDL particles in CVID patients compared to controls. TG levels correlated positively with CRP (rho = 0.256, P = 0.015), IL-6 (rho = 0.237, P = 0.021), IL-12 (rho = 0.265, P = 0.009), LPS (r = 0.654, P = 6.59 × 10(−13)), CVID-specific gut dysbiosis index (r = 0.315, P = 0.048), and inversely with a favorable fatty acid profile (docosahexaenoic acid [rho =  − 0.369, P = 0.021] and linoleic acid [rho =  − 0.375, P = 0.019]). TGs and VLDL lipids did not appear to be associated with diet and there were no differences in body mass index (BMI) between CVID patients and controls. CONCLUSION: We found increased plasma levels of TGs and all sizes of VLDL particles, which were associated with systemic inflammation, LPS, and gut dysbiosis in CVID, but not diet or BMI. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10875-023-01475-x. Springer US 2023-03-30 2023 /pmc/articles/PMC10353950/ /pubmed/36995502 http://dx.doi.org/10.1007/s10875-023-01475-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Macpherson, Magnhild E.
Skarpengland, Tonje
Hov, Johannes R.
Ranheim, Trine
Vestad, Beate
Dahl, Tuva B.
Fraz, Mai S. A.
Michelsen, Annika E.
Holven, Kirsten B.
Fevang, Børre
Berge, Rolf K.
Aukrust, Pål
Halvorsen, Bente
Jørgensen, Silje F.
Increased Plasma Levels of Triglyceride-Enriched Lipoproteins Associate with Systemic Inflammation, Lipopolysaccharides, and Gut Dysbiosis in Common Variable Immunodeficiency
title Increased Plasma Levels of Triglyceride-Enriched Lipoproteins Associate with Systemic Inflammation, Lipopolysaccharides, and Gut Dysbiosis in Common Variable Immunodeficiency
title_full Increased Plasma Levels of Triglyceride-Enriched Lipoproteins Associate with Systemic Inflammation, Lipopolysaccharides, and Gut Dysbiosis in Common Variable Immunodeficiency
title_fullStr Increased Plasma Levels of Triglyceride-Enriched Lipoproteins Associate with Systemic Inflammation, Lipopolysaccharides, and Gut Dysbiosis in Common Variable Immunodeficiency
title_full_unstemmed Increased Plasma Levels of Triglyceride-Enriched Lipoproteins Associate with Systemic Inflammation, Lipopolysaccharides, and Gut Dysbiosis in Common Variable Immunodeficiency
title_short Increased Plasma Levels of Triglyceride-Enriched Lipoproteins Associate with Systemic Inflammation, Lipopolysaccharides, and Gut Dysbiosis in Common Variable Immunodeficiency
title_sort increased plasma levels of triglyceride-enriched lipoproteins associate with systemic inflammation, lipopolysaccharides, and gut dysbiosis in common variable immunodeficiency
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353950/
https://www.ncbi.nlm.nih.gov/pubmed/36995502
http://dx.doi.org/10.1007/s10875-023-01475-x
work_keys_str_mv AT macphersonmagnhilde increasedplasmalevelsoftriglycerideenrichedlipoproteinsassociatewithsystemicinflammationlipopolysaccharidesandgutdysbiosisincommonvariableimmunodeficiency
AT skarpenglandtonje increasedplasmalevelsoftriglycerideenrichedlipoproteinsassociatewithsystemicinflammationlipopolysaccharidesandgutdysbiosisincommonvariableimmunodeficiency
AT hovjohannesr increasedplasmalevelsoftriglycerideenrichedlipoproteinsassociatewithsystemicinflammationlipopolysaccharidesandgutdysbiosisincommonvariableimmunodeficiency
AT ranheimtrine increasedplasmalevelsoftriglycerideenrichedlipoproteinsassociatewithsystemicinflammationlipopolysaccharidesandgutdysbiosisincommonvariableimmunodeficiency
AT vestadbeate increasedplasmalevelsoftriglycerideenrichedlipoproteinsassociatewithsystemicinflammationlipopolysaccharidesandgutdysbiosisincommonvariableimmunodeficiency
AT dahltuvab increasedplasmalevelsoftriglycerideenrichedlipoproteinsassociatewithsystemicinflammationlipopolysaccharidesandgutdysbiosisincommonvariableimmunodeficiency
AT frazmaisa increasedplasmalevelsoftriglycerideenrichedlipoproteinsassociatewithsystemicinflammationlipopolysaccharidesandgutdysbiosisincommonvariableimmunodeficiency
AT michelsenannikae increasedplasmalevelsoftriglycerideenrichedlipoproteinsassociatewithsystemicinflammationlipopolysaccharidesandgutdysbiosisincommonvariableimmunodeficiency
AT holvenkirstenb increasedplasmalevelsoftriglycerideenrichedlipoproteinsassociatewithsystemicinflammationlipopolysaccharidesandgutdysbiosisincommonvariableimmunodeficiency
AT fevangbørre increasedplasmalevelsoftriglycerideenrichedlipoproteinsassociatewithsystemicinflammationlipopolysaccharidesandgutdysbiosisincommonvariableimmunodeficiency
AT bergerolfk increasedplasmalevelsoftriglycerideenrichedlipoproteinsassociatewithsystemicinflammationlipopolysaccharidesandgutdysbiosisincommonvariableimmunodeficiency
AT aukrustpal increasedplasmalevelsoftriglycerideenrichedlipoproteinsassociatewithsystemicinflammationlipopolysaccharidesandgutdysbiosisincommonvariableimmunodeficiency
AT halvorsenbente increasedplasmalevelsoftriglycerideenrichedlipoproteinsassociatewithsystemicinflammationlipopolysaccharidesandgutdysbiosisincommonvariableimmunodeficiency
AT jørgensensiljef increasedplasmalevelsoftriglycerideenrichedlipoproteinsassociatewithsystemicinflammationlipopolysaccharidesandgutdysbiosisincommonvariableimmunodeficiency